The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.
Janine Austin Clayton, MDPeer
A. Paul Chous, MA, OD, FAAO, CDEPeer
Anne Peters, MDPeer
Charles Wykoff, MD, PhDPeer
Michael H. Davidson, MDPeer
You need to be logged in to save this episode to a playlist.